Login / Signup
Dapeng Li
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Lymph Node
Phase Ii Study
Neoadjuvant Chemotherapy
Double Blind
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yihebali Chi
,
Xiangqian Zheng
,
Yuan Zhang
,
Feng Shi
,
Ying Cheng
,
Zhuming Guo
,
Ming-Hua Ge
,
Jianwu Qin
,
Jiewu Zhang
,
Zhendong Li
,
Xiaohong Zhou
,
Rui Huang
,
Xiao-Hong Chen
,
Hui Liu
,
Ruochuan Cheng
,
Zhengang Xu
,
Dapeng Li
,
Pingzhang Tang
,
Ming Gao
Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase Ⅱ Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)